TSPO and central nervous system cancer: In vitro competition binding assays showed that [18F]BIBD-239 has high affinity to TSPO, and animal models of stroke and glioma showed high and displaceable uptake in the lesions, although no significant displacement was observed in the healthy areas of the rat brain [25].